FDB Launches Clinical Decision Support Analytics Solution
Healthcare Organizations Gain Actionable Insights into the Effectiveness of Clinical Decision Support Across the Care Continuum
FDB the leading provider of drug and medical device knowledge that helps healthcare professionals make precise decisions, announced the launch of FDB CDS Analytics during the 2021 HIMSS Global Conference & Exhibition in Las Vegas. The solution enables healthcare provider organizations to easily identify, monitor and customize clinical decision support (CDS) in their electronic health record (EHR), which ultimately helps enhance clinician user experiences and advances CDS impact across all care areas to improve patient outcomes.
Recommended AI News: BrightEdge SearchIQ Provides Customers With A New And Complementary Intelligent Edge
FDB is launching CDS Analytics with Indianapolis-based Community Health Network as an early adopter. Community Health Network is a non-profit health system with more than 200 sites of care and affiliates throughout Central Indiana, integrating hundreds of physicians, eight specialty and acute care hospitals, surgery centers, home care services, MedCheck urgent care clinics, behavioral health, and employer health services.
“Community Health Network is excited to build a deeper partnership with FDB as an early adopter of FDB CDS Analytics,” said Patrick McGill, MD, Chief Analytics Officer, Community Health Network. “We are constantly looking for opportunities to extend our analytics capabilities with innovations to more easily understand the impact of CDS. With FDB CDS Analytics, we gain a more thorough view of which clinical decision support is effective and which CDS rules are not working as intended, which enables us to identify opportunities for improved clinical decision support. With the evidence and education, we can then put these advanced CDS rules into practice, ultimately resulting in improved clinician user experiences, increased ROI and better patient care.”
Recommended AI News: Graystone Company Forecasted Revenue From Bitcoin Mining Operation
FDB CDS Analytics is a cloud-based web application that leverages the health system’s data warehouse, along with FDB’s highly respected drug knowledge and expertise, to offer pre-configured metrics and reports to track the effectiveness of decision support. The solution offers easy-to-understand dashboards designed for different roles within the organization, such as chief medical information officers, pharmacy directors, analysts and other stakeholders, and the ability to view trends across the entire institution, at the departmental level and even for the individual clinician.
FDB CDS Analytics can help organizations identify alerts that are ineffectual or may require optimization, leading to reduced alert volume and increased alert acceptance. Over-alerting, combined with safety alarms from medical devices and the EHR, contributes to clinician burnout. That is why as recently as 2020 the ECRI Institute ranked alert fatigue among its Top 10 Health Technology Hazards.
FDB President Bob Katter said, “Clinical decision support tools are essential in modern EHR workflows, but it can be difficult for healthcare organizations to determine which CDS initiatives are providing clinicians with the optimal guidance they need at the right time and which are just contributing to alert fatigue. FDB CDS Analytics simplifies and accelerates the process of evaluating CDS across their organization with an intuitive and powerful tool that offers deeper insight into how clinicians are using CDS. This insight also informs how CDS can be adapted to more effectively support clinicians in the delivery of safe and high-quality patient care.”
CDS Analytics is part of FDB’s new PatientFirst Care Guidance solutions. FDB is dedicated to making the patient and their unique circumstances the center of clinical decision support via targeted, actionable, and timely care guidance that helps improve outcomes and increases clinician satisfaction. PatientFirst Care Guidance also includes FDB AlertSpace®, FDB Targeted Medication Warnings™ and FDB’s pharmacogenomic clinical decision support.
“FDB has been, and continues to be, the leading provider of medication decision support with unmatched clinical expertise and experience,” Katter said. “That experience, plus our knowledge of clinical workflows, enables us to provide the industry’s most innovative, robust CDS analytics solution to support quality and safety goals—whether they involve medications, care management, testing, clinician experience or all of the above.”